NCT03507647

Brief Summary

The current study will be a randomized controlled trial (RCT) investigating the clinical and cost-effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) as an adjunct to usual care, versus usual care alone, in reducing depressive symptoms in patients with bipolar disorder. Outcome measures include depressive, (hypo)manic and anxiety symptoms, risk of relapse/recurrence, functioning and mental health/well-being. The study also aims to explore possible working mechanisms such as improvements of mindfulness and self-compassion skills. The study will have a follow-up duration of 15 months from baseline.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
144

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2018

Typical duration for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 18, 2017

Completed
7 months until next milestone

Study Start

First participant enrolled

April 23, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 25, 2018

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 16, 2020

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 17, 2021

Completed
Last Updated

April 18, 2023

Status Verified

April 1, 2023

Enrollment Period

2.2 years

First QC Date

September 18, 2017

Last Update Submit

April 14, 2023

Conditions

Keywords

randomized controlled trialMindfulness based cognitive therapyclinical effectivenesscost-effectivenessworking mechanisms

Outcome Measures

Primary Outcomes (1)

  • Inventory of Depressive Symptomatology

    A clinican-administered interview assessing the severity of depressive symptoms

    Change between baseline and 3 months

Secondary Outcomes (19)

  • Structured Clinical Interview for DSM-IV-TR Disorders

    Change between baseline and 15 months

  • Young Mania Rating Scale

    Change between baseline and 3 months

  • Young Mania Rating Scale

    Change between baseline and 15 months

  • Functioning Assessment Short Test

    Change between baseline and 3 months

  • Functioning Assessment Short Test

    Change between baseline and 15 months

  • +14 more secondary outcomes

Other Outcomes (12)

  • Euro-Quality of Life 5D-5L

    baseline

  • Euro-Quality of Life 5D-5L

    3 months

  • Euro-Quality of Life 5D-5L

    6 months

  • +9 more other outcomes

Study Arms (2)

Mindfulness Based Cognitive Therapy added to usual care

EXPERIMENTAL

Patients in the MBCT arm will be invited to participate in MBCT added to their usual care.

Behavioral: Mindfulness Based Cognitive TherapyOther: Usual Care

Usual Care

ACTIVE COMPARATOR

Usual care will typically consist of pharmacotherapy, psycho-education and self-management interventions (usually with a psychiatric nurse).

Other: Usual Care

Interventions

MBCT is a manualised group skills-training program (Segal, Williams \& Teasdale 2012) consisting of eight weekly sessions of 2.5 hours, plus one day of silent practice. The program includes both formal and informal meditation exercises. Cognitive techniques that are part of the program are education, monitoring and scheduling of activities, identification of negative automatic thoughts and devising a relapse prevention plan. The MBCT treatment will be adapted to address the needs of patients with a bipolar disorder. A few examples of these adaptations are: (more) psychoeducation about manic symptoms in addition to the psychoeduction about depression; introducing the 3-minute breathing space earlier in the programme and more often during sessions, especially when strong emotions are present; repeatedly bringing the focus to self-care; and making use of the mindful movement (yoga) exercises more frequently.

Also known as: MBCT, Mindfulness training
Mindfulness Based Cognitive Therapy added to usual care

Usual care will typically consist of pharmacotherapy, psycho-education and self-management interventions (usually with a psychiatric nurse). Usual care will not be restricted, except for proscribing high-frequency psychological interventions such as (group) cognitive behavioral therapy, for practical and methodological reasons.

Mindfulness Based Cognitive Therapy added to usual careUsual Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • bipolar I or II disorder
  • having suffered at least two lifetime depressive episodes, either current or in (partial) remission at baseline (according to SCID assessment)
  • Young Mania Rating Scale score \< 8

You may not qualify if:

  • a manic episode in the 3 months before the start of the trial
  • lifetime diagnosis of schizophrenia or schizoaffective disorder, current substance abuse disorder, organic brain syndrome, antisocial or borderline personality disorder
  • risk of suicide or aggression
  • the presence of a concurrent significant medical condition impeding the ability to participate
  • currently receiving regular psychological therapy
  • previous participation in a MBCT or MBSR course

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Radboud University Nijmegen Medical Center

Nijmegen, Gelderland, 6525 GC, Netherlands

Location

Dimence GGZ

Deventer, Netherlands

Location

Pro Persona

Nijmegen, Netherlands

Location

Altrecht GGZ

Utrecht, Netherlands

Location

Related Publications (4)

  • Hanssen I, Huijbers M, Regeer E, Lochmann van Bennekom M, Stevens A, van Dijk P, Boere E, Havermans R, Hoenders R, Kupka R, Speckens AE. Mindfulness-based cognitive therapy v. treatment as usual in people with bipolar disorder: A multicentre, randomised controlled trial. Psychol Med. 2023 Oct;53(14):6678-6690. doi: 10.1017/S0033291723000090. Epub 2023 Mar 7.

  • Hanssen I, Scheepbouwer V, Huijbers M, Regeer E, Lochmann van Bennekom M, Kupka R, Speckens A. Adverse or therapeutic? A mixed-methods study investigating adverse effects of Mindfulness-Based Cognitive Therapy in bipolar disorder. PLoS One. 2021 Nov 4;16(11):e0259167. doi: 10.1371/journal.pone.0259167. eCollection 2021.

  • Hanssen I, van der Horst N, Boele M, Lochmann van Bennekom M, Regeer E, Speckens A. The feasibility of mindfulness-based cognitive therapy for people with bipolar disorder: a qualitative study. Int J Bipolar Disord. 2020 Nov 11;8(1):33. doi: 10.1186/s40345-020-00197-y.

  • Hanssen I, Huijbers MJ, Lochmann-van Bennekom MWH, Regeer EJ, Stevens AWMM, Evers SMAA, Wensing M, Kupka RW, Speckens AEM. Study protocol of a multicenter randomized controlled trial of mindfulness-based cognitive therapy and treatment as usual in bipolar disorder. BMC Psychiatry. 2019 Apr 30;19(1):130. doi: 10.1186/s12888-019-2115-6.

MeSH Terms

Conditions

Bipolar Disorder

Interventions

Mindfulness-Based Cognitive Therapy

Condition Hierarchy (Ancestors)

Bipolar and Related DisordersMood DisordersMental Disorders

Intervention Hierarchy (Ancestors)

MindfulnessCognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Anne Speckens, Prof.

    Radboud University Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcomes will be assessed by independent research assistants blind to condition. Participants will be instructed to avoid unblinding as much as possible.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized, multicenter, prospective, evaluator-blinded clinical trial of MBCT added to treatment as usual (TAU) versus TAU alone
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. dr.

Study Record Dates

First Submitted

September 18, 2017

First Posted

April 25, 2018

Study Start

April 23, 2018

Primary Completion

June 16, 2020

Study Completion

June 17, 2021

Last Updated

April 18, 2023

Record last verified: 2023-04

Locations